J L
Oct 14, 2014

Pharma Patent Regime May Get Stricter


In order to boost dollar inflows in pharma sector and establish stronger IPR regime, govt may affect patent amendments. The joint statement issued on September 30 by the US and India to establish an annual high-level Intellectual Property (IP) working group has inevitably led to a debate on whether the government would bow down to the US pressure. A section of the pharmaceutical industry feels that the government may give importance to increasing the dollar in-flows through foreign direct investments (FDI) rather than pushing the case of a "diluted" intellectual property rights (IPR) regime that the country followed so far.